An angel investor who funds healthcare and medical device firms, Ari Kellen harnesses his prior experience as an operating executive to grow the firms he funds. One company that Ari Kellen contributes to is Theraclion, a manufacturer of novel, noninvasive treatments to shrink tumors.
Theraclion’s products address multiple health conditions using related ultrasound technologies. Robotic instruments are used by physicians to perform noninvasive procedures, aiming for sufficient efficacy and safety to provide an alternative to surgery, minimizing recovery time and side effects. Physicians can use the company’s products in non-sterile environments, increasing accessibility and patient convenience.
For example, Theraclion’s trademark product, Echo Pulse, shrinks thyroid nodules and breast fibroadenoma when applied to the target area. The physician directs the thermal energy with a high-intensity ultrasound (HIFU) probe, and the HIFU passes through the skin. Sonovein utilizes similar technology, directing HIFU to shrink and seal varicose veins without wire punctures or scars.
